Skip to main content

Featured

Holiday Turbulence: Flight Delays Hit Major Canadian Airports on Boxing Day

  Passengers wait in a check-in line at Vancouver International Airport after a snowstorm crippled operations during the holidays in 2022.   Travelers across Canada are facing a challenging Boxing Day as major airports report widespread delays and cancellations triggered by winter weather and heavy post‑holiday traffic. With thousands of passengers returning home or heading out for year‑end vacations, the timing couldn’t be more disruptive. Toronto Pearson, the country’s busiest airport, is experiencing the most significant impact. A mix of snow, freezing drizzle, and strong winds has slowed de‑icing operations and reduced runway capacity. Long lines at security and check‑in counters are adding to the congestion, with some travelers reporting wait times stretching beyond an hour. Ottawa, Montreal, and Vancouver airports are also dealing with delays, though to varying degrees. In Eastern Canada, Halifax is managing a combination of fog and residual holiday traffic, while air...
Post a Comment
Read more

article

Labels

U.S. Drug Tariffs: A Looming Crisis for Global Supply Chains


The U.S. government's decision to impose tariffs on pharmaceutical imports has sent shockwaves through the healthcare industry, raising concerns about potential drug shortages and skyrocketing costs. Industry leaders warn that these tariffs could disrupt critical supply chains, affecting the availability of essential medications and medical devices.

Johnson & Johnson CEO Joaquin Duato has voiced concerns over the impact of these tariffs, advocating for tax incentives instead of trade barriers to support domestic drug manufacturing Warns Tariffs Could Disrupt U.S. Drug Supply Chains](https://www.theglobeandmail.com/investing/markets/stocks/LLY-N/pressreleases/31903548/jj-ceo-jnj-warns-tariffs-could-disrupt-us-drug-supply-chains/). Meanwhile, a recent survey indicates that healthcare executives anticipate significant price hikes, with some predicting an 18% increase in medical equipment costs and a 33% rise in critical device prices.

The American Hospital Association has urged the administration to reconsider these tariffs, emphasizing the reliance of U.S. healthcare providers on international sources for life-saving drugs and supplies. Experts caution that while the tariffs aim to boost domestic production, the transition could take years, leaving patients vulnerable to shortages and inflated prices.

As pharmaceutical companies scramble to adjust their supply chains, the industry faces an uncertain future. Whether these tariffs will achieve their intended goal or exacerbate existing challenges remains to be seen. Policymakers must weigh the long-term consequences carefully to ensure that patient care and affordability are not compromised.

Labels:

Comments

Post a Comment